How should I manage a 34-year-old woman with hyperlipidemia and fatty liver who has severe post‑miscarriage headaches that are unrelieved by oxycodone 5 mg?

Management of Severe Post-Miscarriage Headaches Unrelieved by Oxycodone

Discontinue oxycodone immediately and initiate evidence-based migraine therapy with IV metoclopramide 10 mg plus ketorolac 30 mg, as opioids are contraindicated for headache management and provide no therapeutic benefit while risking dependency and medication overuse headache. 1, 2, 3

Critical First Step: Stop Opioid Therapy

• Opioids including oxycodone are explicitly contraindicated for migraine and headache treatment because they lead to dependency, rebound headaches, and eventual loss of efficacy 2
• The FDA labeling confirms oxycodone is indicated only for "pain severe enough to require an opioid pain medicine, when other pain treatments do not treat your pain well enough"—headache does not meet this criterion 3
• The American College of Physicians strongly advises avoiding opioids and butalbital-containing medications for migraine treatment 2
• The failure of oxycodone to provide relief confirms this is likely migraine or another primary headache disorder, not opioid-responsive pain 1

Immediate Assessment: Rule Out Secondary Causes

Before treating as primary headache, exclude life-threatening conditions:

• Screen for preeclampsia/eclampsia: The American College of Obstetricians and Gynecologists mandates excluding preeclampsia/eclampsia in any new headache in a woman of childbearing age, especially post-pregnancy 1
  • Check blood pressure immediately
  • Order urinalysis for proteinuria
  • Consider postpartum preeclampsia even weeks after miscarriage
• Consider cerebral venous sinus thrombosis: Pregnancy and the postpartum period increase thrombotic risk 4
  • If any focal neurological signs, obtain urgent brain MRI with venography 4
• Assess for subarachnoid hemorrhage: If thunderclap onset or "worst headache of life," perform CT head and lumbar puncture if CT negative 1

Acute Treatment for Severe Refractory Headache

The combination of metoclopramide and ketorolac represents the most evidence-based IV approach for severe refractory migraine and should be administered first-line. 1

First-Line IV Therapy (Status Migrainosus Protocol)

• Metoclopramide 10 mg IV: Provides direct analgesic effects through central dopamine receptor antagonism, recommended by the American Headache Society as first-line treatment 1
• Ketorolac 30 mg IV: Offers rapid onset with 6-hour duration and minimal rebound headache risk 1
• This combination is superior to either agent alone and should be given together 1
• Alternative: Prochlorperazine 10 mg IV has comparable efficacy to metoclopramide with a more favorable side effect profile 1

Second-Line Options if First-Line Fails

• Dihydroergotamine (DHE) IV or intranasal: Has good evidence for efficacy as monotherapy for acute migraine attacks 1, 2
  • Particularly useful in intranasal formulation for refractory cases 2
  • Contraindicated if uncontrolled hypertension present 2
• Corticosteroids (dexamethasone or prednisone): Should be reserved for status migrainosus after other options have failed 1

Hepatic Considerations with Fatty Liver

• Oxycodone is extensively metabolized in the liver, and the FDA labeling specifically warns that clearance may decrease in patients with hepatic impairment 3
• This provides an additional reason to avoid opioids in this patient 3
• NSAIDs like ketorolac are generally safe in non-alcoholic fatty liver disease without cirrhosis 5
• Metoclopramide dosing does not require adjustment for fatty liver without cirrhosis 1

Transition to Outpatient Management

Once acute headache is controlled, establish a sustainable treatment plan:

Acute Abortive Therapy for Future Episodes

• Sumatriptan 50-100 mg PLUS naproxen sodium 500 mg: Combination therapy provides sustained pain relief at 48 hours and is superior to either agent alone 1, 2
• Alternative: Gepants (ubrogepant 50-100 mg or rimegepant): Primary alternative to triptans with no vasoconstriction and safe in cardiovascular disease 1, 2
• Critical frequency limitation: The American Headache Society mandates strictly limiting all acute migraine medications to no more than 2 days per week (10 days per month) to prevent medication overuse headache 1, 2

Preventive Therapy Initiation

Preventive therapy should be initiated immediately given the severity and recent onset of frequent headaches. 1

• Propranolol 80-240 mg/day: Has the most consistent evidence for efficacy and should be the first choice for preventive therapy 1
• Alternative: Amitriptyline 30-150 mg/day: Particularly useful if there is a mixed migraine and tension-type headache pattern 1
• Avoid topiramate and divalproex sodium: Both are teratogenic and should be avoided in women of childbearing potential not using reliable contraception 1
• The American Headache Society recommends preventive therapy for patients with two or more attacks per month producing disability lasting 3+ days or failure of acute treatments 1

Medication Overuse Headache Risk

• The American Headache Society defines medication overuse headache (MOH) as acute medication use ≥10 days/month for triptans or ≥15 days/month for NSAIDs 1
• If the patient has been using oxycodone frequently since the miscarriage, she may already have developed MOH 1
• If MOH is present, the cycle must be broken by withdrawing the overused medication while simultaneously initiating preventive therapy 1

Common Pitfalls to Avoid

• Never continue opioid therapy for headache: This patient's provider made an error prescribing oxycodone for headache—it has no role and causes harm 2, 3
• Do not delay preventive therapy: Given severity requiring emergency care, preventive therapy should start immediately, not after "trying acute treatments" 1
• Do not miss postpartum preeclampsia: This can occur weeks after pregnancy loss and is life-threatening if untreated 1
• Do not ignore the fatty liver: While it doesn't contraindicate most headache treatments, it does increase oxycodone toxicity risk and should be documented 3